Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
TEZSPIRE Inj Lös 210 mg/1.91ml Fertspr 1.91 ml
Drug
Tezspire, Injektionslösung in einer Fertigspritze
Zusatztherapie bei schwerem Asthma
03.04.5. – other antiasthmatics
HAM – Human medicine
INLFS – Solution for injection in pre-filled syringe
BT – biological medicines
B – Dispensed on prescription by a physician or veterinarian (B)
Z – approved
6/13/2022
6/12/2027
Dosage strength
Tezspire, Injektionslösung in einer Fertigspritze
Zusatztherapie bei schwerem Asthma
01
Z – approved
Package
7680684540011
No information made available
A/R – Authorised / referenced
1 pre-filled syringe(s)
001
Z – approved
Declaration
Component
210 mg tezepelumabum
prolinum
acidum aceticum glaciale
polysorbatum 80
natrii hydroxidum
aqua ad iniectabile
acidum aceticum glaciale
polysorbatum 80
natrii hydroxidum
aqua ad iniectabile
Spezialitätenliste***
SL
-
-
1249.35
None
Yes
10%
No
Authorisation holder
7601001348622
AstraZeneca AG
Neuhofstrasse 34
6340 Baar (ZG)
Neuhofstrasse 34
6340 Baar (ZG)
Date of revision of the text
3/19/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.